Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Clinical evidence for weight loss benefit is weak
[8] Absolute contraindications include prior hypersensitivity to cyanocobalamin, cobalt, or formulation excipients
Low NAD+ links to age-related diseases like cardiovascular issues, metabolic disorders, neurodegeneration, and cancer.[3][16] For example, in Alzheimer's models, NAD+ depletion exacerbates amyloid plaque formation and neuronal death
Key Differences Between AOD 9604 and MOTS-C | Feature | AOD 9604 | MOTS-C | |-----------------------|-------------------------------------|----------------------------------------| | Origin | HGH fragment | Mitochondrial peptide | | Primary function | Fat metabolism and fat loss | Cellular energy regulation and metabolism | | Effects on hormones | Minimal impact on HGH and insulin | Improves insulin sensitivity | | Common goals | Weight loss, fat reduction | Energy boost, metabolic health | | Research status | Several clinical trials on fat loss | Emerging research on metabolism | These differences mean the peptides serve different purposes, even though both relate to metabolism
Daily protocols use a small subcutaneous dose calculated from your weight and goal
US$ 28.27
US$ 27.29
US$ 28.86
US$ 21.29
